阿尔茨海默病
疾病
半乳糖凝集素-3
半乳糖凝集素
神经科学
半乳糖凝集素-1
医学
心理学
免疫学
内科学
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2019-05-23
卷期号:364 (6442): 747.4-748
标识
DOI:10.1126/science.364.6442.747-d
摘要
Neurodegeneration
The role of the innate immune system and inflammation in Alzheimer's disease is currently undergoing scrutiny. Galectin-3 has been identified as a protein that is highly up-regulated in brain microglia during neurodegeneration and aging. Boza-Serrano et al. analyzed the potential role of galectin-3 in Alzheimer's disease pathology. They found that galectin-3 was highly up-regulated in brains from Alzheimer's disease patients, particularly in microglia associated with amyloid plaques. A similar distribution was seen in mouse models of Alzheimer's disease. Polymorphisms in the gene encoding galectin-3 were associated with increased risk of Alzheimer's disease. In mouse models, reducing galectin-3 expression ameliorated plaque burden and improved cognitive behaviors. Furthermore, direct injections of galectin-3 and amyloid into wild-type mice induced amyloid aggregation in the hippocampus. Further work will be needed to confirm whether inhibiting galectin-3 could provide an approach to Alzheimer's disease treatment or prevention.
Acta Neuropathol. 10.1007/s00401-019-02013-z (2019).
科研通智能强力驱动
Strongly Powered by AbleSci AI